Ceylon cinnamon and its major compound Cinnamaldehyde can limit overshooting inflammatory signaling and angiogenesis in vitro: implications for COVID-19 treatment
K. Lucas, M. Ackermann, A. L. Leifke, W. W. Li, U. Poeschl, J. Froehlich-Nowoisky
This study shows that Ceylon cinnamon and cinnamaldehyde reduce inflammatory signaling and angiogenesis in vitro, potentially allowing lower dexamethasone doses for COVID-19 treatment.
bioRxiv · Jun 16, 2021 · PreprintImmunology